NEWS

Autophagy targets in neurodegeneration

Autophagy targets in neurodegeneration

We are excited to announce a new collaboration which has been set up through the Milner Therapeutics Consortium to investigate autophagy targets in...

Affiliate Companies showcase their work

Affiliate Companies showcase their work

As we reach the end of what has been the most challenging and difficult year so far, we want to take the time to celebrate the achievements of our...

Milner Consortium reaches 10

Milner Consortium reaches 10

We are excited to announce that two new pharma partners — Eli Lilly and Company and Bristol Myers Squibb — have joined the Milner Consortium in the...

Kathryn Lilley awarded EMBO membership

Kathryn Lilley awarded EMBO membership

We are delighted to announce that Kathryn Lilley, Director of the Cambridge Centre for Proteomics, is among 63 leading scientists who have been...

Milner seminars move online

Milner seminars move online

We have been busy adapting plans for the coming months, and are pleased to announce that our Milner seminars are moving online. The first talk is...

Providing COVID-19 support

Providing COVID-19 support

Thank you to the numerous Milner affiliated companies who have been in contact to offer support  to the University and NHS at this time. Help tackle...

Milner Institute closure for COVID-19

Milner Institute closure for COVID-19

As part of the response to COVID-19 at the University of Cambridge, the Milner Therapeutics Institute will be closed for non-essential business from...

Welcome to the Tzelepis Group

Welcome to the Tzelepis Group

We are delighted that Dr Konstantinos Tzelepis has moved into the Milner Centre for Pathway Analysis as a new Academic in Residence. He brings...

A look inside the institute

A look inside the institute

For the past four years, the Milner Therapeutics Institute has been incubating in the Gurdon Institute – home to the research lab of our Director...

First pre-competitive project initiated

First pre-competitive project initiated

A key goal of the Milner Therapeutics Consortium is to enable collaborations between Cambridge academics and our Consortium companies using...

New University Enterprise Zone announced

New University Enterprise Zone announced

The Milner Therapeutics Institute will form part of a University Enterprise Zone, created through a new government initiative announced today by...

Pin It on Pinterest